Hematology/Oncology

Top Story

10 essential updates for Breast Cancer Awareness Month

October 19, 2019
In the Journals

Patient preference for maximal thyroid cancer surveillance linked to increased use of resources

October 18, 2019
Patients with thyroid cancer who opt for maximal vs. minimal surveillance after being declared disease-free consume a greater amount of health care resources without…

Breast surgeon to lead Duke Cancer Institute's clinical cancer genetics program

October 18, 2019
Carolyn Menendez, MD, FACS, has been appointed director of Duke Cancer Institute’s clinical cancer genetics program. Menendez — assistant professor of…
In the Journals

Concizumab effective, safe for certain patients with hemophilia

October 18, 2019
Concizumab appeared safe and demonstrated clinical proof of concept in preventing bleeds among patients with hemophilia A and hemophilia A or B with inhibitors…
Feature

ID1 inhibition may improve efficacy of glioblastoma treatment

October 18, 2019
Investigators from St. Michael’s Hospital and The Hospital for Sick Children in Toronto have determined that the transcriptional regulatory protein ID1 appears to…
More Headlines »
CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making – Rapid Response From Amsterdam

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video
Meeting News

VIDEO: Initial results of ZUMA-3 trial ‘highly encouraging’ for relapsed, refractory leukemia

July 21, 2019
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Acute Lymphoblastic Leukemia Posters and Abstracts from San Diego

This activity is supported by educational funding provided by Amgen.

In this CME activity Elias Jabbour, MD, provides his perspectives on key posters presented at the American Society of…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next